A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes and emphasizing the need for clinical trials.
Pfizer Antiviral Paxlovid’s Extended Use Shows Mixed Results for Long COVID Relief: Study
